Patient-derived organoids contribute to precision medicine by enabling direct drug testing on a patient’s tumor. These models ...

Researchers from UTS and Monash University have identified vitronectin as a key protein driving abnormal lung scarring in ...

For more than 25 years, lab-on-a-chip technology has allowed researchers to model human organs and blood vessels using real ...

For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...

Researchers have uncovered a surprising culprit behind sleep loss in Alzheimer’s disease: the brain’s own immune cells. In ...

A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...

Pulmonary fibrosis is a deadly disease in which scar tissue grows in the lungs, making breathing more difficult.

The pharmaceutical industry loses billions each year on drug candidates that perform well in animal testing but ultimately fail in human trials, most often because of safety concerns. As regulators ...

Choosing the best pharmacy college today is about far more than earning a degree. Students want institutions that combine academic rigour with practic ...

Families at George Mark Children’s House either have a child living with a life limiting condition, or a child who is dying.

Pulmonary fibrosis is a deadly disease where scar tissue grows in the lungs, making breathing more difficult. Approximately 2 ...